Therapeutic role of lymph node resection in endometrioid corpus cancer

作者: John K. Chan , Michael K. Cheung , Warner K. Huh , Kathryn Osann , Amreen Husain

DOI: 10.1002/CNCR.22185

关键词:

摘要: BACKGROUND. The purpose of the current study was to determine potential therapeutic role lymphadenectomy in women with endometrioid corpus cancer. METHODS. Demographic and clinicopathologic information were obtained from Surveillance, Epidemiology, End Results Program between 1988–2001. Data analyzed using Kaplan-Meier methods Cox proportional hazards regression. RESULTS. In all, 12,333 (median age, 64) underwent surgical staging lymph node assessment, including 9,009, 1,211, 1,223, 890 Stage I-IV disease. Over time intervals 1988–1992, 1993–1997, 1998–2001, percentage patients undergoing increased 22.6%, 29.6%, 40.9% (P 20) associated improved 5-year disease-specific survivals across all 5 groups at 75.3%, 81.5%, 84.1%, 85.3%, 86.8%, respectively < .001). For IIIC-IV nodal disease, extent resection significantly survival 51.0%, 53.0%, 60.0%, 72.0%, However, no significant benefit low-risk could be demonstrated (Stage IA, grades; IB, Grades 1 2 disease; P = .23). In multivariate analysis, a more extensive remained prognostic factor for intermediate/high-risk after adjusting other factors year diagnosis, stage, grade, adjuvant radiotherapy, presence positive nodes .001). CONCLUSIONS. The findings suggest that improves uterine cancer. Cancer 2006. © 2006 American Society.

参考文章(22)
N.P. Koper, L.A.L.M. Kiemeney, C.M.G. Thomas, L.F.A.G. Massuger, A.L.M. Verbeek, Serum ca 125 measurements to identify patients with endometrial cancer who require lymphadenectomy Anticancer Research. ,vol. 18, pp. 1897- 1902 ,(1998)
Arden D Chan, Richard Essner, Leslie A Wanek, Donald L Morton, Judging the therapeutic value of lymph node dissections for melanoma Journal of The American College of Surgeons. ,vol. 191, pp. 16- 22 ,(2000) , 10.1016/S1072-7515(00)00313-6
Karl C. Podratz, Andrea Mariani, Maurice J. Webb, Staging and Therapeutic Value of Lymphadenectomy in Endometrial Cancer Gynecologic Oncology. ,vol. 70, pp. 163- 164 ,(1998) , 10.1006/GYNO.1998.5150
L. Weir, C. Speers, Y. D’yachkova, I. A. Olivotto, Prognostic Significance of the Number of Axillary Lymph Nodes Removed in Patients With Node-Negative Breast Cancer Journal of Clinical Oncology. ,vol. 20, pp. 1793- 1799 ,(2002) , 10.1200/JCO.2002.07.112
G. Scambia, A. Gadducci, P.Benedetti Panici, E. Foti, M. Ferdeghini, G. Ferrandina, M. Amoroso, C. Castellani, V. Facchini, S. Mancuso, Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma Gynecologic Oncology. ,vol. 54, pp. 292- 297 ,(1994) , 10.1006/GYNO.1994.1213
David N. Krag, Richard M. Single, Breast Cancer Survival According to Number of Nodes Removed Annals of Surgical Oncology. ,vol. 10, pp. 1152- 1159 ,(2003) , 10.1245/ASO.2003.03.073
D.Scott McMeekin, Daphne Lashbrook, Michael Gold, Dennis R. Scribner, Scott Kamelle, Todd D. Tillmanns, Robert Mannel, Nodal distribution and its significance in FIGO stage IIIc endometrial cancer Gynecologic Oncology. ,vol. 82, pp. 375- 379 ,(2001) , 10.1006/GYNO.2001.6278
Deborah J. Dotters, Preoperative CA 125 in endometrial cancer: is it useful? American Journal of Obstetrics and Gynecology. ,vol. 182, pp. 1328- 1334 ,(2000) , 10.1067/MOB.2000.106251